Analysts’ Perspective: Correvio Pharma (CORV), Fitbit (FIT), Oceaneering International (OII)

Investment Analysts at Mackie Research upgrade Correvio Pharma Corp. (NASDAQ:CORV) shares from Hold to Buy rating.

Correvio Pharma Corp., a specialty pharmaceutical company, provides various products to meet the needs of acute care physicians and patients worldwide.


Brokerage Firm Wedbush upgraded Fitbit, Inc. (NYSE:FIT) shares from Neutral to Outperform rating.

Fitbit, Inc., a technology company, provides health solutions in the United States and internationally.


Oceaneering International, Inc. (NYSE:OII) shares were upgraded by analysts at Societe Generale from Hold to Buy rating.

Oceaneering International, Inc. provides engineered services and products to the offshore oil and gas, defense, aerospace, and commercial theme park industries worldwide.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at